Page last updated: 2024-09-03

ulipristal acetate and Substance Withdrawal Syndrome

ulipristal acetate has been researched along with Substance Withdrawal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bucella, D; Fastrez, M; Revercez, P; Rozenberg, S; Vandromme, J	1

Other Studies

1 other study(ies) available for ulipristal acetate and Substance Withdrawal Syndrome

Article	Year
Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic! European journal of obstetrics, gynecology, and reproductive biology, 2020, Volume: 252 Topics: Adult; Aged; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Pandemics; Pneumonia, Viral; Risk Assessment; Risk Factors; Safety-Based Drug Withdrawals; SARS-CoV-2; Substance Withdrawal Syndrome; Uterine Neoplasms; Withholding Treatment	2020

Article

Year

Suspension of ulipristal acetate for uterine fibroids during ongoing EMA's review of liver injury risk: Unfortunate timing during the Covid-19 pandemic!

European journal of obstetrics, gynecology, and reproductive biology, 2020, Volume: 252

Topics: Adult; Aged; Betacoronavirus; Chemical and Drug Induced Liver Injury; Coronavirus Infections; COVID-19; Female; Humans; Leiomyoma; Middle Aged; Norpregnadienes; Pandemics; Pneumonia, Viral; Risk Assessment; Risk Factors; Safety-Based Drug Withdrawals; SARS-CoV-2; Substance Withdrawal Syndrome; Uterine Neoplasms; Withholding Treatment

2020